16:02 Dec 20
Wanbury Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Wanbury Ltd.
55/100 High Financial Strength
Quality42/100 Mid Valuation
Valuation68/100 Technically Moderately Bullish
TechnicalSWOT
Strength
8
Weakness
8
Opportunity
1
Threat
0
932.29
Market Cap (Cr)
17.60
PE Ratio
24.06
Price to Book Ratio
53.47
RSI
9.72 %
Net Profit Margin
SWOT
Download Our App On:
